Hunan Kelun Pharmaceutical Co., Ltd. clinical trials
Acquired by Sichuan Kelun Pharmaceutical Co.,Ltd., 2003 · source ↗
The registry lists 8 studies whose lead sponsor is Hunan Kelun Pharmaceutical Co., Ltd.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 18, 2026.
Before and after it joined Sichuan Kelun Pharmaceutical Co.,Ltd.
- First submitted before Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- 0
- First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- 8
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Hunan Kelun Pharmaceutical Co., Ltd.8 studies
Something wrong with this grouping? Tell us on the Sichuan Kelun Pharmaceutical Co.,Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Sichuan Kelun Pharmaceutical Co.,Ltd. studies →
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult SubjectsNot yet recruitingNCT07828470Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy VolunteersRecruitingNCT07474545Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- A Phase I Study of KLA318-2 Nanocrystal InjectionRecruitingNCT07171034Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- Single-dose,First-in-human of KLA478RecruitingNCT07240675Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- First-in-Human Single and Multiple Dose of KLA578-1 for InjectionRecruitingNCT07143318Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride InjectionCompletedNCT07710560Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- Bioequivalence Study of Gefitinib Tablets Under Fasting ConditionsCompletedNCT03050164Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.
- Bioequivalence Study of Gefitinib Tablets Under Fed ConditionsCompletedNCT03050177Phase 1
Sponsor listed in the registry: Hunan Kelun Pharmaceutical Co., Ltd. · First submitted after Hunan Kelun Pharmaceutical Co., Ltd. became part of Sichuan Kelun Pharmaceutical Co.,Ltd.